Associations of serum ferritin and transferrin % saturation with all-cause, cancer, and cardiovascular disease mortality: Third National Health and Nutrition Examination Survey follow-up study

Journal of Preventive Medicine and Public Health

Volumn 45, Issue 3, 2012, Pages 196-203

  Kim, Ki Su ^a   Son, Hye Gyeong ^a   Hong, Nam Soo ^a   Lee, Duk Hee ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

Cardiovascular diseases; Ferritins; Iron; Mortality; Neoplasms; Transferrin saturation

Indexed keywords

FERRITIN; IRON; TRANSFERRIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEOPLASM; POSTMENOPAUSE; PUBLIC HEALTH; TRANSFERRIN BLOOD LEVEL;

AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; FERRITINS; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; REPUBLIC OF KOREA; TRANSFERRINS;

EID: 84863110934     PISSN: 19758375     EISSN: None     Source Type: Journal    
DOI: 10.3961/jpmph.2012.45.3.196     Document Type: Article

References (33)

1. Crichton RR. Inorganic biochemistry of iron metabolism. New York: E. Horwood; 1991.
2. Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990;186:1-85. (Pubitemid 20279941)
3. Halliwell B. Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic Res 1996;25(1):57-74. (Pubitemid 26245475)
4. Sempos CT, Looker AC, Gillum RE, McGee DL, Vuong CV, Johnson CL. Serum ferritin and death from all causes and cardiovascular disease: the NHANES II Mortality Study. National Health and Nutrition Examination Study. Ann Epidemiol 2000;10(7):441-448.
5. Mainous AG 3rd, Gill JM, Carek PJ. Elevated serum transferrin saturation and mortality. Ann Fam Med 2004;2(2):133-138. (Pubitemid 39329081)
6. Sempos CT, Looker AC, Gillum RF, Makuc DM. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994;330(16):1119-1124. (Pubitemid 24118269)
7. Menke A, Muntner P, Fernandez-Real JM, Guallar E. The association of biomarkers of iron status with mortality in US adults. Nutr Metab Cardiovasc Dis 2011; in press.
8. Ellervik C, Tybjærg-Hansen A, Nordestgaard BG. Total mortality by transferrin saturation levels: two general population studies and a metaanalysis. Clin Chem 2011;57(3):459-466.
9. Jia X, Aucott LS, McNeill G. Nutritional status and subsequent all-cause mortality in men and women aged 75 years or over living in the community. Br J Nutr 2007;98(3):593-599. (Pubitemid 47272875)
10. Lee DH, Zacharski LR, Jacobs DR Jr. Comparison of the serum ferritin and percentage of transferrin saturation as exposure markers of iron-driven oxidative stress-related disease outcomes. Am Heart J 2006;151(6):1247.e1-1247. e7.
11. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. Vital Health Stat 1 1994;(32):1-407.
12. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey: NCHS research ethics review board (ERB) approval [cited 2011 Sep 28]. Available from: http://www.cdc.gov/nchs/nhanes/irba98.htm.
13. National Center for Health Statistics. The third National Health and Nutrition Examination Survey (NHANES III) linked mortality file: mortality follow-up through 2006; 2009 [cited 2011 Sep 28]. Available from: http://www.cdc.gov/nchs/data/datalinkage/matching-methodology-nhanes3-final.pdf.
14. National Center for Health Statistics (NCHS). Third National Health and Nutrition Examination Survey (NHANES III) linked mortality file: public-use file layout and detailed notes for selected variables [cited 2011 sep 28]. Available from: http://www.cdc.gov/nchs/data/datalinkage/nh3-file-layout-public-2010.pdf.
15. Anderson RN, Minino AM, Hoyert DL, Rosenberg HM. Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. Natl Vital Stat Rep 2001;49(2):1-32.
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40(5):373-383. (Pubitemid 17055592)
17. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47(11):1245-1251. (Pubitemid 24361532)
18. Charlson ME, Charlson RE, Peterson JC, Marinopoulos SS, Briggs WM, Hollenberg JP. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol 2008;61(12):1234- 1240.
19. Korn EL, Graubard BI. Epidemiologic studies utilizing surveys: accounting for the sampling design. Am J Public Health 1991;81(9):1166-1173.
20. Graubard BI, Korn EL. Analyzing health surveys for cancer-related objectives. J Natl Cancer Inst 1999;91(12):1005-1016. (Pubitemid 29293039)
21. Davis DL, Hoel D, Fox J, Lopez A. International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA. Lancet 1990;336(8713):474-481. (Pubitemid 20264222)
22. Fox CS, Evans JC, Larson MG, Kannel WB, Levy D. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham Heart Study. Circulation 2004;110(5):522-527. (Pubitemid 39031167)
23. Beaton GH, Corey PN, Steele C. Conceptual and methodological issues regarding the epidemiology of iron deficiency and their implications for studies of the functional consequences of iron deficiency. Am J Clin Nutr 1989;50(3 Suppl):575-585.
24. Cook JD, Finch CA, Smith NJ. Evaluation of the iron status of a population. Blood 1976;48(3):449-455.
25. Cook JD, Lipschitz DA, Miles LE, Finch CA. Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr 1974;27(7):681-687.
26. Stevens RG, Cologne JB, Nakachi K, Grant EJ, Neriishi K. Body iron stores and breast cancer risk in female atomic bomb survivors. Cancer Sci 2011;102(12):2236-2240.
27. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86(3):803-811.
28. Klipstein-Grobusch K, Koster JF, Grobbee DE, Lindemans J, Boeing H, Hofman A, et al. Serum ferritin and risk of myocardial infarction in the elderly: the Rotterdam Study. Am J Clin Nutr 1999;69(6):1231-1236. (Pubitemid 29252058)
29. Cross AJ, Sinha R, Wood RJ, Xue X, Huang WY, Yeager M, et al. Iron homeostasis and distal colorectal adenoma risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Prev Res (Phila) 2011;4(9):1465-1475.
30. Manttari M, Manninen V, Huttunen JK, Palosuo T, Ehnholm C, Heinonen OP, et al. Serum ferritin and ceruloplasmin as coronary risk factors. Eur Heart J 1994;15(12):1599-1603.
31. You SA, Wang Q. Ferritin in atherosclerosis. Clin Chim Acta 2005;357(1):1-16. (Pubitemid 40814431)
32. Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, et al. Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem 1992;267(25):18148-18153.
33. Reif DW. Ferritin as a source of iron for oxidative damage. Free Radic Biol Med 1992;12(5):417-427.